AI assistant
Rua Bioscience Limited — Earnings Release 2022
Aug 26, 2022
66262_rns_2022-08-26_747a66b1-56fd-4f98-94bd-d4dfe824858f.pdf
Earnings Release
Open in viewerOpens in your device viewer
MARKET ANNOUNCEMENT
==> picture [133 x 77] intentionally omitted <==
FOR PUBLIC RELEASE NZX Limited Wellington
26 August 2022
Rua Bioscience FY22 results to be announced on 29 August 2022
Rua Bioscience Limited (NZX:RUA) advises that its results for the 12 months to 30 June 2022 will be released on Monday 29 August 2022. Management will host a briefing for investors, analysts and media at:
11am on Tuesday 30 August
Participants can register for the briefing at:
https://s1.c-conf.com/diamondpass/10024687-asfmw4.html
A dial-in number, passcode, and a unique access PIN will be emailed to you as a calendar invitation.
A call transcript will be available in the Investor section of the Rua website several days after the call.
ENDS
For further information, please contact:
Hamish White Rua Bioscience CFO 0800 RUA BIO [email protected]
For media or investor enquiries, please contact:
Kerry Donovan Communications Manager [email protected]
About Rua
Rua Bioscience (RUA:NZX) is a New Zealand pharmaceutical company that is a pioneer in the New Zealand medicinal cannabis sector. Established in 2017 to support economic development in Te Tairāwhiti, Rua holds a licence to operate in the medicinal cannabis sector commercially, has two commercial-scale facilities and holds a contract with German distributer Nimbus Health to supply dried flower. Rua’s extensive knowledge of the global market and expertise in: cannabis plant chemistry and analytics; cultivation and growth optimisation; and processing and pharmaceutical manufacturing supports its strategy to identify long-term value opportunities. www.ruabio.com